Microcap stock jumps 4% after bagging ₹14 Crore worth of orders from multiple entities

Synopsis: Concord Drugs Limited has recently received orders worth Rs. 14 Crores from multiple government entities for supply of various pharmaceutical products. 

The shares of this micro-cap company is majorly engaged in developing new products with innovative drug delivery technologies by utilizing best and latest processing machinery, jumped upto 4 percent after bagging multiple orders from government entities. 

With the market capitalization of Rs. 86 Crores the shares of Concord Drug ltd have touched intraday high of Rs. 86.4 per share, raised upto 4 percent from its previous day close of Rs. 83.11 per share. 

Concord Drugs Ltd has received new domestic orders from several government healthcare bodies in December 2025 to supply various pharmaceutical products. These orders have come from Tamil Nadu Medical Services Corporation, including 6 purchase orders and 32 orders under the Mudhalvar Marundhagam Scheme, along with orders from the Directorate General of Health Services, Telangana State Medical Services & Infrastructure Development Corporation, and other entities. 

The total value of these orders is around ₹14.71 crore and is expected to have a positive impact on the business and operations of the Company. The supplies are expected to be completed within the next 45 to 60 days. 

Concord Drugs Limited is an India-based pharmaceutical company that makes a wide range of medicines, including injectables, tablets, capsules, eye medicines, dry syrups, tissue bio-adhesive products, and ready-to-fill pellets. The company runs two approved manufacturing plants in Andhra Pradesh and Hyderabad, with separate facilities for liquid injections, dry powder injections, and pellet production to maintain good quality standards. 

Year-on-Year analysis: Revenue from operations has decreased from Rs. 11.84 Crores to Rs. 10.07 Crores, down 15 percent. Operating profit has increased from Rs. 0.79 Crores to  Rs. 1.01 Crores, up 27.8  percent  and net profit has increased from Rs. 0.05 Crore to 0.19 Crores, up 280 percent 

Quarter on Quarter analysis: Revenue from operations has decreased from Rs. 13.38 Crores to 10.07 Crores, down 24.7 percent. Operating profit has increased from Rs. 0.94 Crores to Rs. 1.01 Crores, up 7.44 percent and net profit has increased from Rs. 0.11 Crores to Rs. 0.19 Crores, up 72.7 percent.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Microcap stock jumps 4% after bagging ₹14 Crore worth of orders from multiple entities appeared first on Trade Brains.